🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to assess the safety and tolerability of MK-36...
Status
Completed
Location
Multiple Locations
Start Date
2014-10
Trial ID
NCT02256553
This is a study to evaluate the efficacy and safety of grass sublingual tab...
Status
Completed
Location
Multiple Locations
Start Date
2011-06
Trial ID
NCT01385371
Treatments Being Tested
This purpose of this study is to determine the efficacy and safety of a gra...
Status
Completed
Location
Multiple Locations
Start Date
2007-11
Trial ID
NCT00562159
The trial is performed to asses efficacy and safety of a sublingual extract...
Status
Completed
Location
Allergopharma GmbH & Co. KG
Start Date
2003-02
Trial ID
NCT00264459
Treatments Being Tested
The purpose of the study is to investigate the efficacy and safety of a gra...
Status
Completed
Location
Multiple Locations
Start Date
2007-11
Trial ID
NCT00550550
Prospective, multicenter, randomized, double-blind, placebo-controlled clin...
Status
Recruiting
Location
Cedt de Tarancón
Start Date
2021-06-14
Trial ID
NCT04891237
Treatments Being Tested
Dose-response trial with a cocktail of recombinant major allergens of Timot...
Status
Completed
Location
Prof. Dr. med. Ludger Klimek
Start Date
2007-09
Trial ID
NCT00666341
The purpose of the study is to try a new route for specific immunotherapy (...
Status
Completed
Location
Dermato-allergological dept. K
Start Date
2010-07
Trial ID
NCT01166269
Treatments Being Tested
Investigation of the clinical efficacy of 3 intralymphatic injections with ...
Status
Completed
Location
Aarhus University Hospital
Start Date
2020-02-01
Trial ID
NCT05191186
Treatments Being Tested
The primary objective of this study is to assess whether the combination of...
Status
Completed
Location
Royal Brompton Hospital
Start Date
2020-11-05
Trial ID
NCT04502966
Treatments Being Tested